TipRanks
Go Ultimate55% OFF

Medacta Group SA (MOVE) Stock Forecast & Price Target

See the Price Targets and Ratings of:

MOVE Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Medacta Group SA in the past 3 months

MOVE Stock 12 Month Forecast

CHF 150.50▲(27.33% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Medacta Group SA in the last 3 months. The average price target is CHF 150.50 with a high forecast of CHF 180.00 and a low forecast of CHF 121.00. The average price target represents a 27.33% change from the last price of CHF 118.20.
Highest Price TargetCHF 180.00Average Price TargetCHF 150.50Lowest Price TargetCHF 121.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:MOVE
Price TargetFollowArticle
Deutsche Bank CHF 121hold2.37%UpsideInitiated09/15/26
Berenberg BankCHF 185→CHF 180buy52.28%UpsideReiterated09/10/26
UBSCHF 151→CHF 148hold25.21%UpsideReiterated07/21/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRVITrevi Therapeutics
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ONCBeOne Medicines

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medacta Group SA

3 Months
Sam England
Sam EnglandBerenberg Bank
Success Rate2/7 ratings generated profit
29%
Average Return
-5.89%

Copying Sam England's trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -5.89% per trade.

1 Year
Sam England
Sam EnglandBerenberg Bank
Success Rate0/7 ratings generated profit
0%
Average Return
-20.03%

Copying Sam England's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -20.03% per trade.

2 Years
Sam England
Sam EnglandBerenberg Bank
Success Rate1/7 ratings generated profit
14%
Average Return
-11.59%

Copying Sam England's trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -11.59% per trade.

MOVE Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for MOVE
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00111
Buy00000
Hold11211
Sell00000
Strong Sell00000
total11322

In the current month, MOVE has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MOVE average Analyst price target in the past 3 months is 150.50.

MOVE Financial Forecast

CHF 0CHF 0.75CHF 1.5CHF 2.25CHF 3Q2 2025Q2 2026Q4 2026
HighCHF 2.55
ConsensusCHF 2.55
LowCHF 2.55

MOVE Earnings Forecast

Next quarter’s earnings estimate for MOVE is CHF 2.55 with a range of CHF 2.55 to CHF 2.55. The previous quarter’s EPS was CHF 1.98. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF 285MCHF 305.4MCHF 325.8MCHF 346.2MCHF 366.6MQ2 2025Q2 2026Q4 2026
HighCHF 367M
ConsensusCHF 361M
LowCHF 356M

MOVE Sales Forecast

Next quarter’s sales forecast for MOVE is CHF 361.02M with a range of CHF 356.04M to CHF 366.62M. The previous quarter’s sales results were CHF 337.93M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

MOVE Stock Forecast FAQ

What is CH:MOVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Medacta Group SA’s 12-month average price target is CHF150.50.
What is CH:MOVE’s upside potential, based on the analysts’ average price target?
Medacta Group SA has 27.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Medacta Group SA a Buy, Sell or Hold?
Medacta Group SA has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Medacta Group SA’s share price target?
The average share price target for Medacta Group SA is CHF150.50. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF180.00, and the lowest forecast is CHF121.00. The average share price target represents a 27.33% increase from the current price of CHF118.2.
What do analysts say about Medacta Group SA?
Medacta Group SA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Medacta Group SA?
To buy shares of CH:MOVE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.